The Topical Tranexamic Acid Have Potential Hazard of Promoting Biofilm Formation of Staphylococcus aureus in Microenvironment of the Prosthetic Joint

Figure 5

CLSM results of biofilm forming with ST1792-sfGFP. (a) Biofilm formation of Staphylococcus aureus in TSBG medium containing 10% SF. (b) Biofilm formation was inhibited by tranexamic acid (10 mg/ml). (c) Biofilm formation was significantly inhibited by tranexamic acid (50 mg/ml). (d) Biofilm formation was significantly inhibited by plasmin. (e, f) Tranexamic acid offset the inhibition of biofilm formation with plasmin.

(a)

(b)

(c)

(d)

(e)

(f)